Nusinersen: The First Option Beyond Supportive Care for Spinal Muscular Atrophy Vikas MaharshiShazia Hasan Review Article 28 July 2017 Pages: 807 - 817
Interventions for Refractory Trigeminal Neuralgia: A Bayesian Mixed Treatment Comparison Network Meta-Analysis of Randomized Controlled Clinical Trials Kannan SridharanGowri Sivaramakrishnan Systematic Review 17 July 2017 Pages: 819 - 831
Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece George GourzoulidisGeorgia KourlabaNikos Maniadakis Original Research Article 12 June 2017 Pages: 833 - 844
Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study Yoshiyuki HamamotoSachiko HonjoHiroyuki Koshiyama Original Research Article 17 June 2017 Pages: 845 - 852
Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial Zahra Ghelich KhanAzita Hajhossein TalasazArash Jalali Original Research Article 12 June 2017 Pages: 853 - 860
Single- and Multiple-Dose Pharmacokinetics, Safety and Tolerability of Lurasidone in Healthy Chinese Subjects Chaoying HuYijun WangJingying Jia Original Research Article 10 July 2017 Pages: 861 - 871
Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men Håkan OlssonNiclas PetriLars Grundemar Original Research Article Open access 28 June 2017 Pages: 873 - 879
Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients? Nuggehally R. Srinivas commentary 08 June 2017 Pages: 881 - 884
Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas Tim HeiseUlrike HövelmannHanne Haahr COMMENTARY 08 June 2017 Pages: 885 - 887
Erratum to: Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study Yuri Aleksandrovich KarpovOn behalf of the FORTISSIMO physicians Erratum 10 July 2017 Pages: 889 - 890